
    
      This is a pilot, non-inferiority clinical trial using historical controls. Participants will
      have whole blood drawn at 0 months, 6 months, and 7 months and receive the HPV vaccine at 0
      months, 6 months, and 12 months. Each blood draw will consist of one 15mL red top tube to
      measure HPV serologies and hormone levels. All blood samples collected will be analyzed at
      the end of the study.
    
  